Fibroblast growth factor 19: potential modulation of hepatic metabolism for the treatment of non-alcoholic fatty liver disease
10.1016/j.neuron.2013.09.004 Neuron 20 BerganzoK.Dez-ArrolaB.TijeroB.SommeJ.LezcanoE.LlorensV.et al (2013)
1) 101108 10.1111/j.1471-4159.2009.05936.x [DOI] [PubMed] [Google Scholar] Wahrle S., Das P., Nyborg A
Potential Applications in the Podiatry Setting While large-scale clinical trials are still limited, heres where BPC-157 and other peptides may find their place in foot care: Chronic plantar fasciitis unresponsive to conservative care Degenerative Achilles tendinopathy Partial ligament injuries that dont require surgery but need help healing Diabetic wound care when healing is stalled Adjunct to regenerative therapies such as laser, shockwave, or platelet-rich plasma Safety and Considerations Peptides like BPC-157 are generally well-tolerated, with few reported side effects
While preliminary evidence supports the adjunctive use of microbiota-targeted therapies alongside conventional hormone replacement, challenges such as individualized intervention design, optimization of microbial formulations, and integration of dietary modulation must be addressed
However, a lot of these studies show that taking GHK does not increase the cancer and it actually helps fight it off
